Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MICAFUNGIN vs MIFEPRISTONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MICAFUNGIN vs MIFEPRISTONE: Safety Overview

Metric MICAFUNGIN MIFEPRISTONE
Total FAERS Reports 3,117 4,492
Deaths Reported 1,068 294
Death Rate 34.3% 6.5%
Hospitalizations 1,121 1,322
Average Patient Age 49.7 yrs 46.2 yrs
% Female Patients 38.7% 84.4%
FDA Approval Date Apr 3, 2025 Apr 11, 2019
Manufacturer Zydus Pharmaceuticals USA Inc. Corcept Therapeutics Incorporated
Route INTRAVENOUS ORAL
Marketing Status Discontinued Prescription